A. ŞAHİN Et Al. , "Elevated checkpoint inhibitor expression and Treg cell number in autosomal dominant polycystic kidney disease and their correlation with disease parameters and hypertension," Clinical and Experimental Medicine , vol.23, no.7, pp.3631-3640, 2023
ŞAHİN, A. Et Al. 2023. Elevated checkpoint inhibitor expression and Treg cell number in autosomal dominant polycystic kidney disease and their correlation with disease parameters and hypertension. Clinical and Experimental Medicine , vol.23, no.7 , 3631-3640.
ŞAHİN, A., KOÇYİĞİT, İ., ASLAN, K., Eroglu, E., DEMİRAY, A., & EKEN, A., (2023). Elevated checkpoint inhibitor expression and Treg cell number in autosomal dominant polycystic kidney disease and their correlation with disease parameters and hypertension. Clinical and Experimental Medicine , vol.23, no.7, 3631-3640.
ŞAHİN, ALİ Et Al. "Elevated checkpoint inhibitor expression and Treg cell number in autosomal dominant polycystic kidney disease and their correlation with disease parameters and hypertension," Clinical and Experimental Medicine , vol.23, no.7, 3631-3640, 2023
ŞAHİN, ALİ Et Al. "Elevated checkpoint inhibitor expression and Treg cell number in autosomal dominant polycystic kidney disease and their correlation with disease parameters and hypertension." Clinical and Experimental Medicine , vol.23, no.7, pp.3631-3640, 2023
ŞAHİN, A. Et Al. (2023) . "Elevated checkpoint inhibitor expression and Treg cell number in autosomal dominant polycystic kidney disease and their correlation with disease parameters and hypertension." Clinical and Experimental Medicine , vol.23, no.7, pp.3631-3640.
@article{article, author={ALİ ŞAHİN Et Al. }, title={Elevated checkpoint inhibitor expression and Treg cell number in autosomal dominant polycystic kidney disease and their correlation with disease parameters and hypertension}, journal={Clinical and Experimental Medicine}, year=2023, pages={3631-3640} }